Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06916221 · ClinicalTrials.gov registry record · NA

BID LTM Digital Intervention in Aging

A NA study of Mild Cognitive Impairment and Inhibitory Control, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06916221: Recruiting NA study of Mild Cognitive Impairment and Inhibitory Control, sponsored by University of California, San Francisco.

NCT06916221 is a NA study of Mild Cognitive Impairment and Inhibitory Control that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 150 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06916221, a NA study of Mild Cognitive Impairment and Inhibitory Control, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

Healthy aging is typically accompanied by diminished capability for learning and retrieval of high-fidelity long-term memory (LTM). The decline in these faculties is accelerated and becomes significant deficits in LTM and cognitive control functions at the level or a diagnosis of Mild Cognitive Impairment (MCI). Training with the navigation game, relative to training with control games, is expected to improve LTM performance for older adult participants. Researchers will compare two different digital interventions to assess whether they may be helpful in improving cognitive function. Participants will conduct study activities remotely (e.g., at-home): 1. Baseline Assessment. Complete a series of cognitive assessments and surveys. 2. Intervention. Engage in a digital intervention for up to 8 weeks. 3. Post Intervention Assessment. Complete the same cognitive assessments and surveys as the Baseline Assessment. 4. Follow-Up Assessment. Six months after the intervention ends, participants will complete the same cognitive assessments and surveys as the Baseline Assessment.

Primary Outcome

Psychometric test for proportion correct in memory for studied images of common objects versus paired similar lures

Interventions

  • BEHAVIORAL Long Term Memory
  • BEHAVIORAL Worder

Study Locations (1)

California

  • University of California, San Francsico - San Francisco

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-08-20
Est. Completion 2028-06-28
Phase NA

What NCT06916221 shows while recruiting

NCT06916221 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Long Term Memory is the first listed.

NCT06916221 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06916221 about?

NCT06916221 is a clinical study titled "BID LTM Digital Intervention in Aging". Healthy aging is typically accompanied by diminished capability for learning and retrieval of high-fidelity long-term memory (LTM). The decline in these faculties is accelerated and becomes significant deficits in LTM and cognitive control functions at the level or a diagnosis of Mild Cognitive Impa...

What is the current status of trial NCT06916221?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-08-20. Estimated completion is 2028-06-28.

What conditions does trial NCT06916221 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Inhibitory Control, Long-Term Memory.

What interventions are being tested in trial NCT06916221?

The interventions under investigation include: Long Term Memory (BEHAVIORAL), Worder (BEHAVIORAL).

Who is sponsoring clinical trial NCT06916221?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06916221 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06916221's enrollment target sits among peer trials

150 64th of 205 higher than 138 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06916221, the US trial registry maintained by the National Library of Medicine. NCT06916221 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.